Petra Munda

553 total citations
20 papers, 319 citations indexed

About

Petra Munda is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Petra Munda has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 15 papers in Hepatology and 3 papers in Oncology. Recurrent topics in Petra Munda's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (6 papers). Petra Munda is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (6 papers). Petra Munda collaborates with scholars based in Austria, Switzerland and Netherlands. Petra Munda's co-authors include Michael Trauner, Emina Halilbasic, Stefan Traussnigg, Harald Hofer, Katharina Staufer, Judith Stift, Gerhard Prager, Magdalena Eilenberg, Christian Kienbacher and Lili Kazemi-Shirazi and has published in prestigious journals such as Gastroenterology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Petra Munda

20 papers receiving 315 citations

Peers

Countries citing papers authored by Petra Munda

Since Specialization

Citations

This map shows the geographic impact of Petra Munda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Munda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Munda more than expected).

Fields of papers citing papers by Petra Munda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Munda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Munda. The network helps show where Petra Munda may publish in the future.

Co-authorship network of co-authors of Petra Munda

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Munda. A scholar is included among the top collaborators of Petra Munda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Munda. Petra Munda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center 2024 ·Scientific Reports ·J. Bernhard, Michael Schwarz, Lorenz Balcar, Benedikt Hofer, (unknown), Robert Straßl, Stephan W. Aberle, Petra Munda, Mattias Mandorfer, Michael Trauner, Thomas Reiberger, Mathias Jachs	2
2	Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression 2023 ·JHEP Reports ·Mathias Jachs, (unknown), Lukas Hartl, Michael Schwarz, Lorenz Balcar, Jeremy V. Camp, Petra Munda, Mattias Mandorfer, Michael Trauner, Stephan W. Aberle, Heinz Zoller, Thomas Reiberger, Péter Ferenci	17
3	Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center 2023 ·United European Gastroenterology Journal ·Mathias Jachs, (unknown), (unknown), (unknown), (unknown), Lukas Hartl, David Bauer, Lorenz Balcar, Robert Straßl, Mattias Mandorfer, Michael Trauner, Petra Munda, Péter Ferenci, Thomas Reiberger	3
4	Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study 2022 ·Alimentary Pharmacology & Therapeutics ·Mathias Jachs, (unknown), (unknown), Teresa Binter, Stephan W. Aberle, Lukas Hartl, (unknown), Elmar Aigner, Albert Friedrich Stättermayer, Petra Munda, Ivo Graziadei, Heidemarie Holzmann, Michael Trauner, Heinz Zoller, Michael Gschwantler, Mattias Mandorfer, Thomas Reiberger, Péter Ferenci	44
5	Sex Disparities in Outcome of Patients with Alcohol-Related Liver Cirrhosis within the Eurotransplant Network—A Competing Risk Analysis 2022 ·Journal of Clinical Medicine ·(unknown), Daniel König, Gabriela Berlakovich, Petra Munda, Péter Ferenci, Dagmar Kollmann, (unknown), Thomas Waldhoer, (unknown), (unknown), Benjamin Vyssoki	7
6	SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis 2022 ·Clinical Gastroenterology and Hepatology ·Lisa Schneider, (unknown), (unknown), Petra Munda, Stefan Winkler, Selma Tobudic	3
7	Induction of pre-s antobodies in HBeAg negative chronic hepatitis B patients by thereupatic vaccination with the pre-s based vaccine VVX001-interim analysis 2022 ·Journal of Hepatology ·Petra Munda, (unknown), Rudolf Stauber, (unknown), Michael Trauner, (unknown), Rudolf Valenta, Péter Ferenci	2
8	Virologic response to bulevirtide is delayed in cirrhotic HDV patients with clinically significant portal hypertension 2022 ·Journal of Hepatology ·Mathias Jachs, (unknown), (unknown), Lukas Hartl, Simona Bota, Petra Munda, Albert Friedrich Stättermayer, Ivo Graziadei, Stephan W. Aberle, Michael Gschwantler, Heinz Zoller, Michael Trauner, Mattias Mandorfer, Péter Ferenci, Thomas Reiberger	1
9	Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity 2021 ·HepatoBiliary Surgery and Nutrition ·Magdalena Eilenberg, Petra Munda, Judith Stift, Felix B. Langer, Gerhard Prager, Michael Trauner, Katharina Staufer	26
10	Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease 2020 ·Wiener klinische Wochenschrift ·Stefan Traussnigg, Emina Halilbasic, Harald Hofer, Petra Munda, Tatjana Stojaković, Günter Fauler, Karl Kashofer, Martin Krššák, Michael Wolzt, Michael Trauner	40
11	Prevalence of anti‐Hepatitis E antibodies and impact on disease severity in non‐alcoholic fatty liver disease 2020 ·Hepatology Research ·Rafael Paternostro, Stefan Traussnigg, Katharina Staufer, Mattias Mandorfer, Emina Halilbasic, Heimo Lagler, Judith Stift, Fritz Wrba, Petra Munda, Michael Trauner	7
12	Non-invasive monitoring of liver disease regression in patients with advanced chronic liver disease after sustained virologic response to INF-free therapies 2020 ·Journal of Hepatology ·Georg Semmler, Teresa Binter, K Kozbial, Philipp Schwabl, David Chromy, David Bauer, Benedikt Simbrunner, Bernhard Scheiner, Theresa Bucsics, Albert Friedrich Stättermayer, Matthias Pinter, Petra Munda, Michael Trauner, Péter Ferenci, Thomas Reiberger, Mattias Mandorfer	2
13	Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease 2019 ·United European Gastroenterology Journal ·Katharina Staufer, Emina Halilbasic, Walter Spindelboeck, Magdalena Eilenberg, Gerhard Prager, Vanessa Stadlbauer, Andreas E. Posch, Petra Munda, Rodrig Marculescu, Barbara Obermayer‐Pietsch, Judith Stift, Carolin Lackner, Michael Trauner, Rudolf Stauber	64
14	Efficacy and safety of the non-steroidal farnesoid X receptor agonist PX-104 in patients with non-alcoholic fatty liver disease (NAFLD) 2017 ·Zeitschrift für Gastroenterologie ·Stefan Traussnigg, Christian Kienbacher, Emina Halilbasic, Heribert Hofer, Petra Munda, Michael Wolzt, Michael Trauner	2
15	1053 Bloom of Fecal Megamonas After a 4 Week High Oral Fructose Challenge Disturbs Energy and Lipid Metabolism: Linking Diet to Microbiota, Bile Acid and Host Metabolism Alterations 2016 ·Gastroenterology ·Christian Kienbacher, Stefan Traussnigg, Emina Halilbasic, Claudia Fuchs, Werner Dolak, Petra Munda, Tatjana Stojaković, Günter Fauler, Michael J. Forster, Femke‐Anouska Heinsen, Malte Rühlemann, André Franke, Michael Trauner	5
16	High Risk for Hepatocellular Carcinoma in Cirrhotic Patients with SVR following IFN-Free Daa Treatment within 1 Year Follow-Up 2016 ·Journal of Hepatology ·K Kozbial, R Stern, C Freissmuth, S. Beinhardt, Albert Friedrich Stättermayer, Petra Munda, Michael Trauner, Péter Ferenci, Heribert Hofer, (unknown)	2
17	Potential of <b><i>nor</i></b>-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders 2015 ·Digestive Diseases ·Michael Trauner, Emina Halilbasic, Thierry Claudel, (unknown), Claudia Fuchs, Tarek Moustafa, Marion J. Pollheimer, Elisabeth Krones, Christian Kienbacher, Stefan Traussnigg, Lili Kazemi-Shirazi, Petra Munda, Harald Hofer, Peter Fickert, G. Paumgartner	33
18	Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH 2015 ·Digestive Diseases ·Stefan Traussnigg, Christian Kienbacher, Emina Halilbasic, (unknown), Lili Kazemi-Shirazi, Harald Hofer, Petra Munda, Michael Trauner	32
19	GLUTAMIC ACID IN WITHDRAWAL AND WEANING IN PATIENTS CLASSIFIED ACCORDING TO CLONINGER'S AND LESCH'S TYPOLOGIES 2006 ·Alcohol and Alcoholism ·Henrik Walter, (unknown), (unknown), Karin Gutiérrez‐Lobos, (unknown), (unknown), Petra Munda, Kenneth Thau, Otto Lesch, Philippe De Witte	16
20	Dysfunction of the liver affects the sense of smell 2005 ·Wiener klinische Wochenschrift ·Andreas F P Temmel, (unknown), Christian Quint, Petra Munda, Peter Ferenci, Thomas Hummel	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact